Cardiff Oncology Inc. (CRDF)
NASDAQ
Closed
Oct 23, 2026
Day's Range
0.890052 wk Range
0.7600Overview - CRDF - Cardiff Oncology Inc.
Key Statistics
Valuation
Enterprise Value
36.03M
P/E (Trailing)
-1.31
P/E (Forward)
-1.68
PEG Ratio
0.03
Price / Sales (TTM)
137.99
Price / Book
2.32
EV / EBITDA
-0.86
Profitability
Profit Margin
0.00%
Operating Margin
-9,245.19%
Return on Assets
-46.72%
Return on Equity
-94.08%
Ownership
Shares Outstanding
68.50M
Float
75.37M
Short % of Shares Outstanding
15.85%
Held by Insiders
6.20%
Held by Institutions
22.07%
Price stats
Beta
1.41
50-Day Avg
1.09
200-Day Avg
1.54
Analyst Consensus
6 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CRDF - Cardiff Oncology Inc.
Peers - CRDF - Cardiff Oncology Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- CRDFNASDAQCardiff Oncology Inc.70.01MMarket Cap-153.33%52-week change-1.31P/E (Trailing)0.00%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - CRDF - Cardiff Oncology Inc.
About
Cardiff Oncology Inc. is a clinical-stage biotechnology company focused on developing cancer therapies that target Polo-like Kinase 1 (PLK1), a validated oncology pathway involved in cell division. Its lead product candidate, onvansertib, is an oral and selective PLK1 inhibitor being studied in combination with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
